Fasting Versus Post-Load Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes : Results From The Botnia Study Running Title : Fasting versus Post-Load Glucose & Diabetes Risk
暂无分享,去创建一个
[1] M. Matsuda,et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.
[2] L. Campbell,et al. Insulin secretion and impaired glucose tolerance , 2010, Diabetologia.
[3] S. Haffner,et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.
[4] M. Matsuda,et al. The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups , 2007 .
[5] L. Groop,et al. Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects , 1996, Diabetes.
[6] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[7] Tamara Harris,et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. , 2005, Diabetes care.
[8] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[9] R. DeFronzo,et al. One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes , 2008, Diabetes Care.
[10] Mark Woodward,et al. A Risk Score for Predicting Incident Diabetes in the Thai Population A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.
[11] R. DeFronzo,et al. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. , 2006, Diabetes care.
[12] M. Stumvoll,et al. Pathogenesis of Type 2 Diabetes , 2007, Endocrine research.
[13] Richard W Morris,et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.
[14] J. Leahy. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .
[15] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[16] M. Matsuda,et al. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. , 2008, American journal of physiology. Endocrinology and metabolism.
[17] J. Shaw,et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[18] Edward J Boyko,et al. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. , 2003, Diabetes care.
[19] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[20] Jaakko Tuomilehto,et al. The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.
[21] S. Haffner,et al. Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.